Results 201 to 210 of about 17,262,511 (380)

1-Year Clinical Outcome Post-Myasthenic Crisis: A Multicenter Prospective Study in China. [PDF]

Eur J Neurol
Huan X, Chen R, Jin L, Wang Y, Xu Y, Yang L, Xi C, Zheng J, Luo L, Yang S, Shi J, Liu Y, Ruan Z, Wu W, Li W, Yue Y, Li Y, Jia W, Zhong H, Yan C, Song J, Xi J, Tan S, Jiang Q, Zou Z, Zhao C, Luo S, Chinese Myasthenia Gravis Collaborating Group (CMGCG).   +27 more
europepmc   +1 more source

Can we predict the clinical outcome of arthroscopic partial meniscectomy? A systematic review

British Journal of Sports Medicine, 2017
S. Eijgenraam, M. Reijman, S. Bierma-Zeinstra, Daan T van Yperen, D. Meuffels   +4 more
semanticscholar   +1 more source

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source

Clinical Outcome of the Oblique Locking Hip Screw. [PDF]

Adv Orthop
Nakagawa S, Toyonaga M, Sawaguchi T, Matsushita T.   +3 more
europepmc   +1 more source

Publishing anaesthetists' clinical outcomes [PDF]

Anaesthesia, 2016
openaire   +2 more sources

Long term follow-up of patients with polycystic ovarian syndrome after laparoscopic ovarian drilling: clinical outcome [PDF]

, 2002
Saad Amer
openalex   +1 more source

SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical Outcome.

American Society of Nephrology. Clinical Journal, 2017
E. J. van Bommel, M. H. Muskiet, L. Tonneijck, M. Kramer, Max Nieuwdorp, D. V. van Raalte   +5 more
semanticscholar   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

Idiopathic Hyperprolactinemia: Clinical Presentation, Diagnosis, Management, and Clinical Outcome. [PDF]

Cureus
Sholuade O, Njoku G, Kaza S, Fatteh RA, Kollukkad M, Edwards C.   +5 more
europepmc   +1 more source

Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients [PDF]

, 2017
Xuanye Zhang, Hui‐Lan Rao, Xiaolu Xu, Zhi‐Hua Li, Bing Liao, Hongmei Wu, Mei Li, Xiuzhen Tong, Juan Li, Qingqing Cai   +9 more
openalex   +1 more source